15 magg 2016 anni - Daily treatment with Vismodegib (Hh
antagonist) downregulated Hh target
genes Gli1, Hhip and Ptch1 and caused
significant reduction of tumour volume
and tumour growth delay.
Descrizione:
Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
Aggiunto al nastro di tempo:
Data:
~ 9 years and 5 months ago